403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Bausch + Lomb Corporation
(MENAFN- Baystreet) 11:30 AM EST - Bausch + Lomb Corporation: Today announced the publication of new research on real world experience with enVista Aspire and enVista Aspire toric intraocular lenses (IOLs). The study, published in the journal Ophthalmology and Therapy, found that these enhanced monofocal lenses delivered both good distance and functional intermediate vision, thus meeting the needs of many cataract patients. Bausch + Lomb Corporation
shares T are trading up $0.46 at $25.36.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment